Truist raises Zymeworks stock price target on pipeline progress
Covered in this story
What has happened since
- Zymeworks Inc is down 9.0% since this was published, 18 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Truist Securities’s $35 target on $ZYME is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Truist Securities’s track record →Analyst targets on Zymeworks Inc
- Jefferies: at $28.2 · target $52 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ZYME yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Zymeworks Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.